Rheumatology

Trials, guidelines and clinical evidence across Rheumatology.

Hydroxychloroquine and COVID-19: Rheumatologists’ role comes into focus

An Annals of the Rheumatic Diseases commentary examines hydroxychloroquine, COVID-19 and why rheumatologists remain central to safe prescribing.

Bibliometric analysis of 1,205 studies maps AS diagnosis research from 2008 to 2024, with MRI, Mendelian randomization, and…

Two-year MANDARA data show durable remission, steroid sparing, and eosinophil depletion with anti-IL-5/R therapy in eosinophilic granulomatosis with…

Rheumatology is moving toward ASAS-defined axial spondyloarthritis terminology, replacing ankylosing spondylitis in diagnosis and classification.

Paired skin and synovial profiling in psoriatic arthritis found heterogeneous IL-23 signaling in joints and tissue-specific response patterns.

A 35-year family study found acute anterior uveitis and a three-question symptom cluster can help identify axial spondyloarthritis…

The scraped feed contains only a copyright notice and no usable clinical abstract, study data, or endpoints to…

A bibliometric analysis of 100 top-cited gout papers found shifting priorities from urate control to long-term outcomes, comorbidity…

EULAR recommendations aim to standardize how ultrasound studies are reported in rheumatic and musculoskeletal diseases to improve reproducibility…

A medRxiv preprint defines three PsA synovial pathotypes using digital histology and machine learning, with a four-marker tissue…

Rheumatology

Trials, guidelines and clinical evidence across Rheumatology.

In Brief The 5-minute rounds